In May 2023, the World Health Organization ( WHO) recommended against using non-sugar sweeteners like sucralose for weight ...

Ben McPoland considers a pair of investments that are performing awfully in his ISA portfolio so far this year. What's gone ...

The lower promoter pledge is expected to enable Aster DM Healthcare to negotiate better terms with its lenders, allowing ...

Friday, Dollar General Corporation (NYSE:DG), currently trading at $77.87 with a market capitalization of $17.15 billion, received a reaffirmed Sector Weight stock rating from KeyBanc, following the ...

Despite these challenges, KeyBanc has chosen to maintain its Sector Weight rating on the stock, citing the current macroeconomic environment and growth challenges in the near term. InvestingPro ...

Over the past year, Infosys has added 4 percent, but recent months have been challenging. In March alone, the stock has dropped nearly 6 percent, following a sharp 10 percent decline in February.

On Monday, KeyBanc Capital Markets maintained its Sector Weight rating on AT&T stock (NYSE ... particularly in terms of EBITDA and free cash flow (FCF). These initiatives include expanding the ...

Novo Nordisk’s vision of 25%-plus weight loss is looking further and further away. Three months after missing that target in its first phase 3 CagriSema trial, the Danish drugmaker has fallen ...

AbbVie has licensed a weight loss candidate from a small biotech ... Lastly, AbbVie is an excellent dividend stock. When counting its time as a division of the medical device giant Abbott ...

NEW YORK, March 10 (Reuters) - President Donald Trump’s tariffs have spooked investors, with fears of an economic downturn driving a stock market sell-off that has wiped out $4 trillion from the ...